SCHEDULE 13G: Manulife Entities Disclose Significant Passive Stake in Veeco Instruments Inc.

Manulife Financial Corporation and its investment management subsidiaries have filed a Schedule 13G, disclosing a combined passive beneficial ownership of approximately 5.17% in Veeco Instruments Inc.

Summary

• Manulife Financial Corporation, along with its indirect wholly-owned subsidiaries Manulife Investment Management Limited (MIML) and Manulife Investment Management (US) LLC (MIM (US)), filed a Schedule 13G with the SEC.
• The filing reports beneficial ownership of common stock in Veeco Instruments Inc. (CUSIP: 922417100).
• Manulife Investment Management (US) LLC holds 2,910,196 shares, representing 5.13% of Veeco Instruments Inc.'s common stock.
• Manulife Investment Management Limited holds 20,119 shares, representing 0.04% of Veeco Instruments Inc.'s common stock.
• Manulife Financial Corporation is deemed to have beneficial ownership of these shares through its parent-subsidiary relationship with MIM (US) and MIML.
• The aggregate beneficial ownership by the Manulife entities totals 2,930,315 shares, representing approximately 5.17% of the class.
• The total shares outstanding for Veeco Instruments Inc. were 56,778,242 as of October 31, 2024, as reported in their Form 10-Q.
• The filing indicates a passive investment purpose, consistent with Rule 13d-1(b), meaning the investors do not intend to change or influence control of the issuer.

Sentiment

Score: 5

Explanation: The document is a factual, regulatory disclosure of beneficial ownership and does not convey a positive or negative sentiment regarding the issuer's performance or prospects. It is a neutral report of an investment position.

Positives

• The disclosure of a significant passive stake by a reputable financial institution like Manulife may signal a degree of confidence in Veeco Instruments Inc.'s long-term prospects from a large institutional investor.

Negatives

• The filing itself does not contain any explicitly negative information regarding Veeco Instruments Inc.

Risks

• The document does not disclose any new or specific risks for Veeco Instruments Inc. beyond the general market risks associated with holding common stock.

Future Outlook

This Schedule 13G filing is a disclosure of current beneficial ownership and does not contain any forward-looking statements or guidance regarding Veeco Instruments Inc.'s future performance or strategic outlook from the reporting persons.

Management Comments

• The document contains certifications and signatures from representatives of the Manulife entities, including Graham Miller (Agent for Manulife Financial Corporation), Christopher Walker (Chief Compliance Officer for Manulife Investment Management Limited), and Paul Donahue (Chief Compliance Officer for Manulife Investment Management (US) LLC), affirming the truthfulness and completeness of the information provided. These are statements from the reporting entity's management, not the issuer's (Veeco Instruments Inc.) management.

Industry Context

This filing represents a routine disclosure by a large institutional asset manager, Manulife, indicating a passive investment in Veeco Instruments Inc. It reflects a standard portfolio allocation decision rather than a strategic industry move or competitive action. Such filings are common in the financial industry as institutional investors cross statutory ownership thresholds.

Stakeholder Impact

• Shareholders of Veeco Instruments Inc. are informed of a significant passive institutional investor holding a stake exceeding 5%, which can be viewed as a vote of confidence by a large asset manager.
• The filing primarily impacts regulatory bodies by providing transparency on significant ownership stakes in publicly traded companies.

Next Steps

• The document does not outline any specific future actions or milestones for Veeco Instruments Inc. or the Manulife entities beyond ongoing regulatory compliance for their investment.

Key Dates

Keywords

Veeco Instruments Inc., Manulife Financial Corporation, Manulife Investment Management, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, Passive Investment, SEC Filing